Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease
Matthias Friedrich, Mathilde Pohin, Fiona Powrie
Immunity (2019) Vol. 50, Iss. 4, pp. 992-1006
Open Access | Times Cited: 591

Showing 1-25 of 591 citing articles:

Pathway paradigms revealed from the genetics of inflammatory bowel disease
Daniel B. Graham, Ramnik J. Xavier
Nature (2020) Vol. 578, Iss. 7796, pp. 527-539
Open Access | Times Cited: 584
The cytokine network involved in the host immune response to periodontitis
Weiyi Pan, Qingxuan Wang, Qianming Chen
International Journal of Oral Science (2019) Vol. 11, Iss. 3
Open Access | Times Cited: 528
The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease
Guillermo Oliver, Jonathan Kipnis, Gwendalyn J. Randolph, et al.
Cell (2020) Vol. 182, Iss. 2, pp. 270-296
Open Access | Times Cited: 515
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology
Luiz G. Almeida, Hayley Thode, Yekta Eslambolchi, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 714-770
Open Access | Times Cited: 268
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier
Giovanni Barbara, Maria Raffaella Barbaro, Daniele Fuschi, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 258
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases
Mineto Ota, Yasuo Nagafuchi, Hiroaki Hatano, et al.
Cell (2021) Vol. 184, Iss. 11, pp. 3006-3021.e17
Open Access | Times Cited: 226
Control of Immunity by the Microbiota
Eduard Ansaldo, Taylor K. Farley, Yasmine Belkaid
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 449-479
Closed Access | Times Cited: 212
Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
Marcello Candelli, Laura Franza, Giulia Pignataro, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6242-6242
Open Access | Times Cited: 211
Ulcerative colitis: Recent advances in the understanding of disease pathogenesis
Ross J Porter, Rahul Kalla, Gwo‐Tzer Ho
F1000Research (2020) Vol. 9, pp. 294-294
Open Access | Times Cited: 203
IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies
Matthias Friedrich, Mathilde Pohin, Matthew Jackson, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 1970-1981
Open Access | Times Cited: 191
ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut
Mengze Lyu, Hiroaki Suzuki, Lan Kang, et al.
Nature (2022) Vol. 610, Iss. 7933, pp. 744-751
Open Access | Times Cited: 181
Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy
Zhaoting Li, Yixin Wang, Jun Liu, et al.
Advanced Materials (2021) Vol. 33, Iss. 38
Closed Access | Times Cited: 175
The role of oral bacteria in inflammatory bowel disease
Emily Read, Michael A. Curtis, Joana F. Neves
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 10, pp. 731-742
Open Access | Times Cited: 139
Roles of Macrophages in the Development and Treatment of Gut Inflammation
Xuebing Han, Sujuan Ding, Hongmei Jiang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 138
Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut
Mousumi Mahapatro, Lena Erkert, Christoph Becker
Cells (2021) Vol. 10, Iss. 1, pp. 111-111
Open Access | Times Cited: 114
Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy
Xiaohua Pan, Qing Zhu, Li‐Long Pan, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108176-108176
Closed Access | Times Cited: 113
CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease
Raquel Gómez-Bris, Ángela Saéz, Beatriz Herrero‐Fernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2696-2696
Open Access | Times Cited: 106
Dihydroquercetin supplement alleviates colonic inflammation potentially through improved gut microbiota community in mice
Fan Wan, Hui Han, Ruqing Zhong, et al.
Food & Function (2021) Vol. 12, Iss. 22, pp. 11420-11434
Closed Access | Times Cited: 105
Gut-innervating nociceptors regulate the intestinal microbiota to promote tissue protection
Wen Zhang, Mengze Lyu, Nicholas J. Bessman, et al.
Cell (2022) Vol. 185, Iss. 22, pp. 4170-4189.e20
Open Access | Times Cited: 93
Oral zero-valent-molybdenum nanodots for inflammatory bowel disease therapy
Chen Zhang, Han Wang, Xinhui Yang, et al.
Science Advances (2022) Vol. 8, Iss. 37
Open Access | Times Cited: 83
Immuno‐Engineered Nanodecoys for the Multi‐Target Anti‐Inflammatory Treatment of Autoimmune Diseases
Mengying Hou, Yuansong Wei, Ziyin Zhao, et al.
Advanced Materials (2022) Vol. 34, Iss. 12
Closed Access | Times Cited: 75
Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy
Polychronis Pavlidis, Anastasia Tsakmaki, Eirini Pantazi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 74
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Yameng Cao, Kai Cheng, Mei Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 65
ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease
Meiyu Bao, Keyi Wang, Jingqiang Li, et al.
Acta Biomaterialia (2023) Vol. 161, pp. 250-264
Closed Access | Times Cited: 60
A Curcumin‐Modified Coordination Polymers with ROS Scavenging and Macrophage Phenotype Regulating Properties for Efficient Ulcerative Colitis Treatment
Hang Yao, Feifei Wang, Hui Chong, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top